Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Magnetic Resonance in Medicine
|
May 31, 2024
Tricuspid valve flow measurement using a deep learning framework for automated valve-tracking 2D phase contrast
Jérôme Lamy, Ricardo A Gonzales, Jie Xiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials
Dean A Fennell, Amit Parmar, Jonathan Shamash, et al.
European Journal of Human Genetics : EJHG
|
August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
Fiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
Peter W Szlosarek, Melissa M Phillips, Iuliia Pavlyk, et al.
Pharmacological Reports : PR
|
May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Melissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Pharmacological Reports : PR
|
April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Melissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Lancet (London, England)
|
May 20, 2008
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
Martin F Muers, Richard J Stephens, Patricia Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
Jaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, et al.
Thorax
|
February 16, 2018
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse, Lesley Bishop, Liz Darlison, et al.
BMJ Open Respiratory Research
|
March 14, 2018
BTS guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse, Lesley Bishop, Liz Darlison, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Magnetic Resonance in Medicine
|
May 31, 2024
Tricuspid valve flow measurement using a deep learning framework for automated valve-tracking 2D phase contrast
Jérôme Lamy, Ricardo A Gonzales, Jie Xiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials
Dean A Fennell, Amit Parmar, Jonathan Shamash, et al.
European Journal of Human Genetics : EJHG
|
August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
Fiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
Peter W Szlosarek, Melissa M Phillips, Iuliia Pavlyk, et al.
Pharmacological Reports : PR
|
May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Melissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Pharmacological Reports : PR
|
April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Melissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Lancet (London, England)
|
May 20, 2008
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
Martin F Muers, Richard J Stephens, Patricia Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
Jaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, et al.
Thorax
|
February 16, 2018
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse, Lesley Bishop, Liz Darlison, et al.
BMJ Open Respiratory Research
|
March 14, 2018
BTS guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse, Lesley Bishop, Liz Darlison, et al.
Page
of 4